NVAX - Novavax Inc
Novavax Inc Logo

NVAX - Novavax Inc

https://www.novavax.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
Neutral
RFK Jr. Rescinds Emergency Authorizations For COVID-19 Vaccines - Novavax ( NASDAQ:NVAX ) , Moderna ( NASDAQ:MRNA ) , Pfizer ( NYSE:PFE ) , BioNTech ( NASDAQ:BNTX )
Benzinga • 2 weeks, 4 days ago • score: 0.03
FDA approves updated Pfizer, Moderna, and Novavax Covid vaccines for high-risk individuals. Pfizer-BioNTech Covid vaccine doses exceed 5 billion distributed globally. The market is reacting to NVIDIA's earnings. Learn how to time your next trade here → Health and Human Services Secretary Robert ...
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company is headquartered in Gaithersburg, Maryland.

52W High
$15.22
52W Low
$5.01

MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
2.68
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
3.56
Forward P/E (<15 better)
2.59
EV/EBITDA (<8 favorable)
1.82
EV/Revenue (<3 favorable)
0.83
P/S (TTM) (<3 favorable)
1.19
P/B (<3 favorable)
34.10
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
8.76%
Institutions (25–75% balanced)
58.30%
Shares Outstanding
162,422,000
Float
136,723,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
1,078,718,000
Gross Profit (TTM)
616,861,000
EPS (TTM)
2.22
Profit Margin (>10% good)
0.39%
Operating Margin (TTM) (higher better)
0.44%
ROE (TTM) (>15% strong)
-8.98%
EPS YoY (Quarterly) (>10% good)
-0.38
Revenue YoY (Quarterly) (>8% good)
-0.42
Momentum
Bearish momentum
Value
-0.0436
Previous
-0.0646
Trend
Rising
Signal Cross
No cross

As of
Sep. 05, 2025